Literature DB >> 28942390

Imaging for structural heart procedures: focus on computed tomography.

John Mooney1, Stephanie L Sellers, Mickaël Ohana, João L Cavalcante, Chesnal D Arepalli, Rominder Grover, Ung Kim, Kapilan Selvakumar, Philipp Blanke, Jonathon A Leipsic.   

Abstract

The success and continued rapid clinical integration of transcatheter valve technologies relies on imaging modalities to guide safe and effective device deployment. In particular, cardiac imaging, using both echocardiography and CT, is an integral resource for the multidisciplinary team. These modalities can provide valuable insight for the proceduralist at each stage of transcatheter-based valve insertion, as they can be used reliably to define the anatomy of interest and its relationship to surrounding structures, determine accurate device sizing, assess patients for valve-in-valve procedures, and screen for adverse features or procedural contraindications. We provide an overview of some of the key aspects of the use of CT and echocardiography in the context of transcatheter aortic valve replacement (TAVR), as well as transcatheter mitral valve replacement (TMVR).

Entities:  

Mesh:

Year:  2017        PMID: 28942390     DOI: 10.4244/EIJ-D-17-00516

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

1.  More than numbers: preprocedural multislice computed tomography analysis in a patient undergoing transcatheter aortic valve implantation.

Authors:  Kerstin Piayda; Katharina Hellhammer; Oliver Maier; Verena Veulemans
Journal:  BMJ Case Rep       Date:  2019-06-11

2.  Reliability and Influence on Decision Making of fully-automated vs. semi-automated Software Packages for Procedural Planning in TAVI.

Authors:  Alexander Meyer; Markus Kofler; Matteo Montagner; Axel Unbehaun; Simon Sündermann; Semih Buz; Christoph Klein; Christof Stamm; Natalia Solowjowa; Maximilian Y Emmert; Volkmar Falk; Jörg Kempfert
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.